Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Heart (British Cardiac Society)|February 10, 2021
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathyGiovanni Vitale, Raffaello Ditaranto, Francesca Graziani, et al.
Heart (British Cardiac Society)|July 6, 2023
Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosisGiulia Saturi, Fernando De Frutos, Maurizio Sguazzotti, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 25, 2024
Incidence and predictors of sudden death in patients with cardiac amyloidosisFernando de Frutos, Giulia Saturi, Esther Gonzalez-Lopez, et al.
Frontiers in Cardiovascular Medicine|July 7, 2023
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression trackingV Parisi, R Baldassarre, V Ferrara, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 31, 2024
Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experienceSimone Longhi, Elena Biagini, Pietro Guaraldi, et al.
Circulation|February 8, 2024
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Marco Canepa, et al.
Journal of Medical Microbiology|January 21, 2021
A large food-borne outbreak of campylobacteriosis in kindergartens and primary schools in Pescara, Italy, May-June 2018Simona Sorgentone, Luca Busani, Paolo Calistri, et al.
European Heart Journal|March 22, 2023
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, et al.
Nature Medicine|January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Joseph A Fraietta, James N Gerson, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
Pageof 11